IJPR  articles are Indexed in SCOPUS (2010 - 2021)Click Here     *Five Years Citation in Google scholar (2016 - 2020) is. 1451*        Now IJPR is Q2 in SJR Ranking     Scopus Coverage of IJPR (2010-2021 Issue 1)            

logo

INTERNATIONAL JOURNAL OF PHARMACEUTICAL RESEARCH

A Step Towards Excellence

IJPR included in UGC-Approved List of Journals - Ref. No. is SL. No. 4812 & J. No. 63703

Published by : Advanced Scientific Research
ISSN
0975-2366
Current Issue
Article In Press
No Data found.
ADOBE READER

(Require Adobe Acrobat Reader to open, If you don't have Adobe Acrobat Reader)

Index Page 1
Click here to Download
IJPR 9[3] July - September 2017 Special Issue

July - September 9[3] 2017

Click to download
 

Article Detail

Label
Label
Adverse Drug Reaction Monitoring: Pharmacovigilance and Artificial Intelligence

Author: NEELAM INJETI, DR.ABHISEK PAL
Abstract: Adverse Drug reactions (ADRs) stay as a test in current medical care, especially given the expanding intricacy of therapeutics, an ageing population and rising multimorbidity. Pharmacovigilance aims at collection, evaluation and reporting of unfavourable functions known as individual Case safety report and consistent observation, understanding and correspondence to product benefit -risk profile and validate Signal Detection and BenefitRisk Management. A cautious prescription history can help a prescriber in understanding the patient’s past experiences with drug treatment, especially in distinguishing past ADRs that may block re-exposure to the medication. The most common technique to identify ADRs is depending on spontaneous reports. Unfortunately, the low revealing pace of spontaneous reports is a genuine limitation of Pharmacovigilance. This article sums up a portion of the vital realities about ADRs reporting and Artificial Intelligence. In light of expanding number of ICSR reporting, the dealing with and preparing of these reports is getting monotonous and tedious occupation including the significant expenses. Consequently, PvPI may likewise embrace the Machine learning (ML) strategies for diminishing labour force, cost and time for ICSR processing. By utilizing information mining and taking electronic Health records (EHRs) into thought, AI encourages PV to give better drug and improved health assistance. This review concludes that AI-empowered supportive networks, when executed effectively, can help in upgrading patient safety. Method: A systematic search to identify and retrieve relevant articles/studies in the PubMed, Medline, Scopus by Google search engine.
Keyword: Pharmacovigilance programme India (PvPI) Adverse drug reactions, Machine learning, ICSR (individual case safety reports), Artificial Intelligence.
DOI: https://doi.org/10.31838/ijpr/2021.13.02.031
Download: Request For Article
 




ONLINE SUBMISSION
USER LOGIN


Username
Password
Login | Register
News & Events
SCImago Journal & Country Rank

Terms and Conditions
Disclaimer
Refund Policy
Instrucations for Subscribers
Privacy Policy

Copyrights Form

0.12
2018CiteScore
 
8th percentile
Powered by  Scopus
Google Scholar

hit counters free